KEGG pathways enriched for interacted genes |
pathway name | pathway description | target genes enrich in pathway | p-value |
|
hsa05210
|
Colorectal cancer |
CCND1,BCL2,BIRC5,AKT1,AKT2, |
8.23E-5 |
hsa05222
|
Small cell lung cancer |
CCND1,BCL2,AKT1,AKT2, |
1.71E-2 |
hsa05200
|
Pathways in cancer |
CCND1,MMP2,BCL2,BIRC5,AKT1,AKT2, |
1.89E-2 |
hsa05215
|
Prostate cancer |
CCND1,BCL2,AKT1,AKT2, |
2.02E-2 |
hsa04630
|
Jak-STAT signaling pathway |
CCND1,MPL,AKT1,AKT2, |
9.65E-2 |
|
hsa05213
|
Endometrial cancer |
CCND1,AKT1,AKT2, |
9.89E-2 |
hsa05223
|
Non-small cell lung cancer |
CCND1,AKT1,AKT2, |
1.06E-1 |
hsa05221
|
Acute myeloid leukemia |
CCND1,AKT1,AKT2, |
1.22E-1 |
hsa05214
|
Glioma |
CCND1,AKT1,AKT2, |
1.42E-1 |
hsa05218
|
Melanoma |
CCND1,AKT1,AKT2, |
1.79E-1 |
hsa05212
|
Pancreatic cancer |
CCND1,AKT1,AKT2, |
1.84E-1 |
hsa04510
|
Focal adhesion |
CCND1,BCL2,AKT1,AKT2, |
1.94E-1 |
hsa05220
|
Chronic myeloid leukemia |
CCND1,AKT1,AKT2, |
1.99E-1 |
hsa04210
|
Apoptosis |
BCL2,AKT1,AKT2, |
2.62E-1 |
hsa04666
|
Fc gamma R-mediated phagocytosis |
AKT1,AKT2,MARCKSL1, |
3.09E-1 |
hsa04722
|
Neurotrophin signaling pathway |
BCL2,AKT1,AKT2, |
5.03E-1 |
|
|
|
|
|
|
Gene ontology terms enriched for interacted genes |
GO terms | GO terms description | target genes enrich in GO term | p-value |
|
GO:0021700
|
developmental maturation |
MMP2,NRCAM,CD44,AKT1, |
1.03E-2 |
GO:0080135
|
regulation of cellular response to stress |
EYA3,AKT1,ZEB2,AKT2, |
1.09E-2 |
GO:0051329
|
interphase of mitotic cell cycle |
CCND1,BCL2,BIRC5,AKT1, |
1.09E-2 |
GO:0051325
|
interphase |
CCND1,BCL2,BIRC5,AKT1, |
1.19E-2 |
GO:0043065
|
positive regulation of apoptosis |
BCL2,TUBB,TOP2A,TEX261,CD44,AKT1, |
1.43E-2 |
|
GO:0043068
|
positive regulation of programmed cell death |
BCL2,TUBB,TOP2A,TEX261,CD44,AKT1, |
1.47E-2 |
GO:0010942
|
positive regulation of cell death |
BCL2,TUBB,TOP2A,TEX261,CD44,AKT1, |
1.51E-2 |
GO:0051276
|
chromosome organization |
EZH2,MLL3,EYA3,BMI1,TOP2A,PARP1, |
2.43E-2 |
GO:0043434
|
response to peptide hormone stimulus |
BCL2,AKT1,PARP1,AKT2, |
3.46E-2 |
GO:0042981
|
regulation of apoptosis |
BCL2,BIRC5,TUBB,TOP2A,TEX261,CD44,AKT1, |
4.36E-2 |
GO:0040008
|
regulation of growth |
BCL2,NRCAM,CD44,AKT1,PARP1, |
4.40E-2 |
GO:0043067
|
regulation of programmed cell death |
BCL2,BIRC5,TUBB,TOP2A,TEX261,CD44,AKT1, |
4.58E-2 |
GO:0010941
|
regulation of cell death |
BCL2,BIRC5,TUBB,TOP2A,TEX261,CD44,AKT1, |
4.66E-2 |
GO:0000082
|
G1/S transition of mitotic cell cycle |
CCND1,BCL2,AKT1, |
5.52E-2 |
GO:0009725
|
response to hormone stimulus |
CCND1,BCL2,AKT1,PARP1,AKT2, |
5.70E-2 |
GO:0045787
|
positive regulation of cell cycle |
CCND1,BIRC5,AKT1, |
5.72E-2 |
GO:0000278
|
mitotic cell cycle |
CCND1,BCL2,BIRC5,TUBB,AKT1, |
5.87E-2 |
GO:0070141
|
response to UV-A |
CCND1,AKT1, |
5.97E-2 |
GO:0009411
|
response to UV |
CCND1,BCL2,AKT1, |
6.11E-2 |
GO:0010212
|
response to ionizing radiation |
CCND1,BCL2,EYA3, |
6.32E-2 |
GO:0001558
|
regulation of cell growth |
BCL2,NRCAM,CD44,AKT1, |
6.59E-2 |
GO:0031667
|
response to nutrient levels |
CCND1,BCL2,CD44,AKT1, |
6.87E-2 |
GO:0009314
|
response to radiation |
CCND1,BCL2,EYA3,AKT1, |
7.16E-2 |
GO:0046328
|
regulation of JNK cascade |
AKT1,ZEB2,AKT2, |
7.38E-2 |
GO:0033273
|
response to vitamin |
CCND1,BCL2,CD44, |
7.60E-2 |
GO:0060562
|
epithelial tube morphogenesis |
BCL2,CD44,ZEB2, |
7.83E-2 |
GO:0010748
|
negative regulation of plasma membrane long-chain fatty acid transport |
AKT1,AKT2, |
7.96E-2 |
GO:0010746
|
regulation of plasma membrane long-chain fatty acid transport |
AKT1,AKT2, |
7.96E-2 |
GO:0001955
|
blood vessel maturation |
MMP2,CD44, |
7.96E-2 |
GO:0010765
|
positive regulation of sodium ion transport |
AKT1,AKT2, |
7.96E-2 |
GO:0009719
|
response to endogenous stimulus |
CCND1,BCL2,AKT1,PARP1,AKT2, |
8.04E-2 |
GO:0032869
|
cellular response to insulin stimulus |
AKT1,PARP1,AKT2, |
8.05E-2 |
GO:0070302
|
regulation of stress-activated protein kinase signaling pathway |
AKT1,ZEB2,AKT2, |
8.28E-2 |
GO:0022403
|
cell cycle phase |
CCND1,BCL2,BIRC5,TUBB,AKT1, |
8.68E-2 |
GO:0009991
|
response to extracellular stimulus |
CCND1,BCL2,CD44,AKT1, |
9.30E-2 |
|
|
|
|
|
|